A composite DNA methylation (DNAm) score derived from the American Heart Association's Life's Essential 8 (LE8) framework predicted carotid intima-media thickness (cIMT) — a validated marker of subclinical atherosclerosis — across 1,432 multigenerational participants in the Young Finns Study. Crucially, a higher parental LE8 DNAm score was associated with 0.022 mm lower offspring cIMT (p=0.02), and in adult offspring, a higher baseline DNAm score predicted 0.030 mm lower cIMT seven years later (p=1.1×10⁻⁵), surviving adjustment for subsequent cardiovascular risk factors. Genes linked to the score were enriched in immune and inflammatory pathways.
This finding is notable because it positions blood-based epigenetic scoring as a potential early-warning biomarker that may capture cumulative lifestyle and environmental cardiovascular burden before clinical disease manifests. While cIMT differences of ~0.03 mm are modest, they carry population-level relevance given atherosclerosis's silent progression. The intergenerational association is intriguing but attenuated after parental risk-factor adjustment, raising the question of whether epigenetic transmission is truly independent or simply mirrors heritable behavioral patterns. Observational design limits causal inference, and the predominantly Finnish cohort constrains generalizability. Plaque outcomes were non-significant, tempering enthusiasm. As a preprint posted to medRxiv and not yet peer-reviewed, these results require independent validation before influencing clinical practice. Still, the work is incrementally important — it extends epigenetic clock research toward cardiovascular-specific methylation architectures and hints that parental lifestyle health leaves measurable biological imprints in offspring vasculature.
